COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Genetic Polymorphisms & The Risk for Sepsis After Trauma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02021552
Recruitment Status : Completed
First Posted : December 27, 2013
Last Update Posted : December 7, 2016
Sponsor:
Information provided by (Responsible Party):
Grant E. O'Keefe, University of Washington

Brief Summary:
The specific aim of this is to establish a cohort of severely injured patients admitted to our trauma center. Investigators will collect DNA, utilizing discarded blood samples, from 3000 injury victims in an effort to identify perhaps 50 - 100 single-nucleotide polymorphisms (SNP) (out of 1000s) that can be used, when taken together, to identify patients at highest risk for developing complicated sepsis and death.

Condition or disease Intervention/treatment
Trauma Other: blood sampling

Detailed Description:
The specific aim of this is to establish a cohort of severely injured patients admitted to our trauma center. Investigators will collect DNA, utilizing discarded blood samples, from 3000 injury victims in an effort to identify perhaps 50 - 100 single-nucleotide polymorphisms (SNP) (out of 1000s) that can be used, when taken together, to identify patients at highest risk for developing complicated sepsis and death

Layout table for study information
Study Type : Observational
Actual Enrollment : 357 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Genetic Polymorphisms & The Risk for Sepsis After Trauma
Study Start Date : June 2013
Actual Primary Completion Date : December 2014
Actual Study Completion Date : December 2015

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
trauma patients
trauma patients 18 years or older requiring treatment in the ICU >24 hours. All subjects will undergo blood sampling.
Other: blood sampling
5 ml blood sampling




Primary Outcome Measures :
  1. Investigators aim to identify up to 100 single-nucleotide polymorphisms (out of 1000s) that can be used, when taken together, to identify patients at highest risk for developing complicated sepsis and death. [ Time Frame: 3 years ]
    The investigators will be studying whether baseline genetic difference can be used in the future to identify patients at high risk and conversely those at low risk for complicated post-traumatic infections.


Biospecimen Retention:   Samples With DNA
White blood cells extracted from discarded blood samples


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Prospective cohort in which patients with severe injury, defined by combined anatomic injuries sufficient to require admission to the intensive care unit for treatment (blood transfusions, mechanical support of respiration) and intensive monitoring that is expected to be required for more than 24 hours, will be enrolled
Criteria

Inclusion Criteria:

Admitted to the Intensive Care Unit (ICU) at Harborview Medical Center after suffering a traumatic injury

  • ability to obtain a 5 ml blood sample
  • Expected to be in the ICU for more than 24 hours

Exclusion Criteria:

  • We will exclude subjects with chronic medical conditions for the reasons stated above as well as vulnerable populations (children, pregnant females, and prisoners)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02021552


Locations
Layout table for location information
United States, Washington
Harborview Medical Center
Seattle, Washington, United States, 998107
Sponsors and Collaborators
University of Washington
Investigators
Layout table for investigator information
Principal Investigator: Grant O'Keefe, MD Professor; Dept of Surgery
Layout table for additonal information
Responsible Party: Grant E. O'Keefe, Professor, University of Washington
ClinicalTrials.gov Identifier: NCT02021552    
Other Study ID Numbers: 44109-A
First Posted: December 27, 2013    Key Record Dates
Last Update Posted: December 7, 2016
Last Verified: December 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: De-identified samples and data will be available to other investigators at the discretion of the Principal Investigator.
Keywords provided by Grant E. O'Keefe, University of Washington:
Trauma
Sepsis
Additional relevant MeSH terms:
Layout table for MeSH terms
Sepsis
Wounds and Injuries
Infection
Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes